Help Advance the Science Behind Nopalea

Help Advance the Science Behind Nopalea

From TriVita Inc.

TriVita’s mission is to help people experience greater wellness through a line of science-based, premium nutritional supplements that address a wide range of health concerns.

Support this campaign

Subscribe to follow campaign updates!

More Info

Help Advance the Science Behind Nopalea for the Good of Mankind

There are many people who suffer unnecessarily from inflammation, one of the primary causes of degenerative disease and at the root of much pain, suffering and numerous modern ills.

Why Is This Study Important?

An esteemed independent research organization will conduct a double-blind, placebo-controlled study to assess people who have inflammation symptoms in their body and the effects of lowering inflammatory indicators with Nopalea versus a placebo.

How Nopalea Can Help Lower Inflammation

The wonder of Nopalea is that it provides targeted supplementation that decreases the volume on inflammatory pathways, which can in turn provide a higher quality of life. But a clinical trial is needed to validate the product efficacy claims before Nopalea’s healing message can reach a broader audience.

How You Can Help The Nopalea Study

In an effort to advance the science behind Nopalea and help more people live healthier, happier lives, we’re currently seeking participants to help fund an independently administered double-blind, placebo-controlled clinical study to validate that Nopalea reduces elevated inflammation and improves quality of life. Double-blind means that neither the doctor nor the patient knows what they’re taking; placebo means that we give some people active Nopalea while others receive a product that looks and tastes like Nopalea but contains no active ingredients. By comparing the two, the trial administrator can determine how much improvement can be attributed to Nopalea.

The Nopalea clinical study will be completed on June 1, 2018. All participants can expect to receive their gifts no later than July 31, 2018. Thank you for your support. 

Campaign Wall

Join the Conversation

Sign in with your Facebook account or